Supplementary Figure 3: Effects of adenosine receptor agonists on spheroid culture. (A) Dose-dependent effects of CV1808
on the growths of two colorectal cancer spheroid lines (HC18T and HC21T). Shown are the mean GEI ± SD (independent experiments, n = 3). Asterisks indicate statistically significant differences from the solvent-only (0 μM) spheroids (P < 0.05; analyzed using one-way ANOVA followed by Tukey's post-test). (B) Reproducibility of the NECA dose-response curves in repeated experiments. The same data sets in Figure 6B were used to perform curve-fitting analyses for the NECA treatment. Shown are fitted curves of the normalized data in three independent experiments. (C) Representative phase-contrast micrographs of CRC-TIC spheroids after treatments with cAMPsignaling activators. Colorectal cancer spheroids (HC18T, HC21T, and HC52T) were cultured with solvent only (DMSO), 10 μM CV1808, 1 μM NECA, or 1 μM forskolin for five days. Scale bar, 200 μm. (D) Reproducibility of the dose-response curves for A 2B inhibitors in repeated experiments. The same data sets in Figure 6D were used to perform the curve-fitting analysis for each A 2B inhibitor treatment. (E) Growth stimulation by three supplementary factors on the slow-growing spheroid lines. Luciferase-expressing spheroids were cultured in the presence of the indicated factor(s) for 3 days. Plotted are the growth rates with means in three independent experiments. Data were analyzed using one-way ANOVA (P values are shown in the graphs) followed by Tukey's post-test. The mean values between the different letters are statistically different (P < 0.05). Note that growth rates in the control spheroids are ~1.0 (dotted lines), which implies their difficulty in growth.
